Therapeutics development for addiction: Orexin-1 receptor antagonists von Perrey, David A., Zhang, Yanan

Volltext

Modified Synthesis of NOP Receptor Antagonist SB612111 von Perrey, David A., Li, Jun-Xu, Zhang, Yanan

Volltext

Improvement of the Metabolic Stability of GPR88 Agonist RTI-13951-33: Design, Synthesis, and Biological Evaluation von Rahman, Md Toufiqur, Decker, Ann M., Ben Hamida, Sami, Perrey, David A., Chaminda Lakmal, Hetti Handi, Maitra, Rangan, Darcq, Emmanuel, Kieffer, Brigitte L., Jin, Chunyang

Volltext

Discovery of Arylsulfonamides as Dual Orexin Receptor Agonists von Zhang, Dehui, Perrey, David A, Decker, Ann M, Langston, Tiffany L, Mavanji, Vijayakumar, Harris, Danni L, Kotz, Catherine M, Zhang, Yanan

Volltext

Antinociceptive, reinforcing, and pruritic effects of the G-protein signalling-biased mu opioid receptor agonist PZM21 in non-human primates von Ding, Huiping, Kiguchi, Norikazu, Perrey, David A., Nguyen, Thuy, Czoty, Paul W., Hsu, Fang-Chi, Zhang, Yanan, Ko, Mei-Chuan

Volltext

Synthesis and Evaluation of Orexin‑1 Receptor Antagonists with Improved Solubility and CNS Permeability von Perrey, David A, Decker, Ann M, Zhang, Yanan

Volltext

Substituted Tetrahydroisoquinolines as Selective Antagonists for the Orexin 1 Receptor von Perrey, David A, German, Nadezhda A, Gilmour, Brian P, Li, Jun-Xu, Harris, Danni L, Thomas, Brian F, Zhang, Yanan

Volltext

The importance of the 6- and 7-positions of tetrahydroisoquinolines as selective antagonists for the orexin 1 receptor von Perrey, David A., Decker, Ann M., Li, Jun-Xu, Gilmour, Brian P., Thomas, Brian F., Harris, Danni L., Runyon, Scott P., Zhang, Yanan

Volltext

Synthesis of Enantiopure PZM21: A Biased Agonist of the Mu‐Opioid Receptor von Perrey, David, Zhang, Dehui, Nguyen, Thuy, Carroll, F. Ivy, Ko, Mei‐Chuan, Zhang, Yanan

Volltext

Toward the Development of Bivalent Ligand Probes of Cannabinoid CB1 and Orexin OX1 Receptor Heterodimers von Perrey, David A, Gilmour, Brian P, Thomas, Brian F, Zhang, Yanan

Volltext

Effect of 1‑Substitution on Tetrahydroisoquinolines as Selective Antagonists for the Orexin‑1 Receptor von Perrey, David A, German, Nadezhda A, Decker, Ann M, Thorn, David, Li, Jun-Xu, Gilmour, Brian P, Thomas, Brian F, Harris, Danni L, Runyon, Scott P, Zhang, Yanan

Volltext

Diaryl urea analogues of SB-334867 as orexin-1 receptor antagonists von Perrey, David A., Gilmour, Brian P., Runyon, Scott P., Thomas, Brian F., Zhang, Yanan

Volltext

Structure-activity relationship studies on the tetrahydroisoquinoline-based orexin 1 receptor antagonists: The 1-benzyl position von Zhang, Yanan, Perrey, David A, Harris, Danni L, German, Nadezhda A, Decker, Ann M, Gilmour, Brian P, Thomas, Brian F

Volltext

The effect of 1-substitution on tetrahydroisoquinolines as selective antagonists for the Orexin-1 receptor von Zhang, Yanan, Perrey, David A, German, Nadezhda A, Decker, Ann M, Thorn, David, Li, Jun-Xu, Gilmour, Brian P, Thomas, B.F, Harris, Danni L, Runyon, Scott P

Volltext

An improved method for cysteine alkylation von Perrey, David A., Uckun, Fatih M.

Volltext

Synthesis of Enantiopure PZM21, A Novel Biased Agonist of the Mu-Opioid Receptor von Perrey, David, Zhang, Dehui, Nguyen, Thuy, Carroll, F Ivy, Ko, Mei-Chuan, Zhang, Yanan

Volltext

Reinforcing, Antinociceptive, and Pruritic Effects of a G Protein‐Biased Mu Opioid Receptor Agonist, PZM21, in Primates von Ding, Huiping, Kiguchi, Norikazu, Perrey, David A., Nguyen, Thuy, Czoty, Paul W., Zhang, Yanan, Ko, Mei‐Chuan

Volltext

Diurnal Increase In Muscle Power Is Not Sustained For Repeated Sprints: 1385 Board #5 1:00 PM - 3:00 PM von Racinais, Sebastien, Bishop, David, Perrey, Stephane

Volltext

A band factorization technique for transition matrix element asymptotics von Perrey-Debain, Emmanuel, Abrahams, I. David

Volltext

Cysteine chloromethyl and diazomethyl ketone derivatives with potent anti-leukemic activity von PERREY, D. A, RAMA KRISHNA NARLA, UCKUN, F. M

Volltext